Free access
Research Article
1 June 2010

Direct Targets of CodY in Staphylococcus aureus

This article has been corrected.


More than 200 direct CodY target genes in Staphylococcus aureus were identified by genome-wide analysis of in vitro DNA binding. This analysis, which was confirmed for some genes by DNase I footprinting assays, revealed that CodY is a direct regulator of numerous transcription units associated with amino acid biosynthesis, transport of macromolecules, and virulence. The virulence genes regulated by CodY fell into three groups. One group was dependent on the Agr system for its expression; these genes were indirectly regulated by CodY through its repression of the agr locus. A second group was regulated directly by CodY. The third group, which includes genes for alpha-toxin and capsule synthesis, was regulated by CodY in two ways, i.e., by direct repression and by repression of the agr locus. Since S. aureus CodY was activated in vitro by the branched chain amino acids and GTP, CodY appears to link changes in intracellular metabolite pools with the induction of numerous adaptive responses, including virulence.
Bacterial survival depends upon the ability to sense and respond to environmental stresses, such as changes in temperature, pH, osmolarity, cell population density, and nutrient availability. Staphylococcus aureus has a well-characterized ability to survive when faced with suboptimal conditions, highlighted by the ability of S. aureus to persist in mammalian hosts both as a commensal and as a pathogen. Many regulators of S. aureus virulence gene expression have been characterized (6). With the exception of the stress-dependent activation of σB and the link between CcpA (catabolite control protein A) and select virulence factor expression (46), however, the specific mechanisms of virulence regulation in response to changes in nutrient availability are largely unknown. The best-characterized regulator of S. aureus virulence in response to environmental changes is the Agr (accessory gene regulator) system. This system, encoded at the agr locus, includes a quorum-sensing mechanism that activates a two-component system that controls synthesis of a regulatory RNA, RNAIII (for a review, see reference 33).
CodY, a highly conserved regulatory protein of stationary-phase adaptation in low-G+C Gram-positive bacteria, is emerging as a regulator of virulence in S. aureus (28, 38, 47) as well as in other Gram-positive pathogens (4, 13, 19, 20, 28-30). First discovered in two nonpathogenic species, Bacillus subtilis and Lactococcus lactis, CodY senses nutrient availability by direct interaction with metabolite effectors. CodY homologs define a unique, winged helix-turn-helix-containing family of transcription factors. For B. subtilis CodY, as well as for CodY proteins from Clostridium difficile, Listeria monocytogenes, and Bacillus cereus, the effectors are GTP and the branched chain amino acids (BCAAs; isoleucine, leucine, and valine) (4, 13, 20, 31, 39, 43). GTP and the BCAAs increase synergistically the affinity of CodY for its DNA target sites (17, 50). CodY proteins from L. lactis and Streptococcus pneumoniae, however, respond only to BCAAs (19, 37). A region of B. subtilis CodY that is important for DNA binding (22) and a second region of the protein that is important for BCAA interaction (23, 50) are highly conserved in CodY proteins from many species, including S. aureus (23).
We recently showed that codY null mutations in two clinical isolates of S. aureus resulted in overexpression of the agr locus, as well as the genes that encode alpha-toxin (hla) and the proteins that synthesize polysaccharide intercellular adhesin (PIA) (icaADBC), a major component of staphylococcal biofilm matrices (28). We have now used global transcriptional analyses and genome-wide in vitro DNA binding analysis to determine the extent to which CodY-dependent regulation of metabolic genes and virulence factors is mediated by the Agr system and whether the specific genes affected by a codY mutation are direct or indirect targets of CodY. Transcriptional analysis revealed that S. aureus CodY contributes to the regulation of many virulence genes in strain UAMS-1, as well as genes involved in amino acid metabolism, carbon flow, nitrogen assimilation, and transport systems. While this work was in progress, Pohl et al. (38) reported that a codY mutation in S. aureus strain Newman causes differential regulation of many genes involved in central metabolism and virulence and that the overexpression of some of these genes is likely due to the overexpression of the agr locus.
We extended this analysis by determining that dozens of genes whose expression is affected by a codY mutation are direct targets of CodY binding. Additionally, DNase I footprinting revealed that purified S. aureus CodY binds to several of these promoters at predicted CodY boxes and that the binding is dependent on the presence of the BCAAs and GTP.


Strains and growth conditions.

Bacterial strains and plasmids used in this study are listed in Table 1. S. aureus strains were grown on tryptic soy agar (TSA) or in tryptic soy broth (TSB; Becton Dickinson Co.) with shaking (250 rpm) at 37°C, maintaining a flask-to-medium volume ratio of 10:1. Antibiotics were used as needed at the following concentrations: erythromycin, 10 μg/ml; kanamycin, 50 μg/ml; neomycin, 50 μg/ml; tetracycline, 3 μg/ml (all obtained from Sigma-Aldrich, St. Louis, MO).

Construction of agr and sarA mutant strains.

The Δagr::tetM mutation from strain RN6911 (49) was introduced into strains UAMS-1 and MS1 (ΔcodY::ermC) (28) by phage φ11-mediated transduction, as described by others (32). Transductants resistant to tetracycline were characterized by PCR analysis to confirm the replacement of the agr locus by the tetM gene. The resulting strains were CM18 (Δagr::tetM) and CM19 (ΔcodY::ermC Δagr::tetM). The sarA::kan mutation from UAMS929 (5) was introduced into strains UAMS-1, MS1, CM18, and CM19 by phage φ11-mediated transduction, generating strains CM20 (sarA::kan), CM21 (Δagr::tetM sarA::kan), CM22 (ΔcodY::ermC sarA::kan), and CM23 (ΔcodY::ermC Δagr::tetM sarA::kan). PCR analysis confirmed the insertion of kan within the sarA gene. All the codY mutant strains were confirmed to be unable to produce CodY protein by immunoblotting with an antibody against B. subtilis CodY (39).

Microarray analysis.

S. aureus colonies from TSA plates were used to inoculate a 3-ml culture in TSB. This flask and four additional 3-ml cultures with successive 100-fold dilutions of the initial inoculum were incubated overnight. The next day, flasks were selected that contained cultures with an optical density at 600 nm (OD600) of 3 to 7 and used to inoculate fresh TSB to a starting OD600 of 0.05. After the bacteria reached an OD600 of between 0.5 and 2, they were diluted again in fresh TSB to an OD600 of 0.05 to ensure that the experimental cultures were adapted to the exponential growth phase. RNA was extracted from exponential-phase samples (OD600, 0.6 to 0.8) and post-exponential-phase samples (OD600, 8 to 11), as previously described (28).
cDNA synthesis, biotin labeling, hybridization, and microarray analysis using Affymetrix S. aureus GeneChips were used as described previously (2). Samples from UAMS-1, MS1, CM18, and CM19 were prepared in duplicate. Data from duplicate experiments were normalized, averaged, and analyzed with GeneSpring GX software (Agilent). A gene was defined as differentially expressed if it exhibited at least a 2-fold change in transcript level in different strains or under different conditions and if the change was statistically significant by Student's t test (P < 0.05).

RT-PCR analysis.

Semiquantitative reverse transcription-PCR (RT-PCR) analysis was done as previously described (28). The following primers were used for cDNA synthesis of each respective gene (see also Table S1 in the supplemental material): OCM74 for oppB, OCM72 for sspA, OCM78 for tst-1, OCM76 for capA, OCM82 for sak, OCM80 for spa, OCM53 for ilvD, and OCD15 for 16S rRNA. The following additional primers were included for PCR amplification of the cDNA: oppB (OCM73), sspA (OCM71), tst-1 (OCM77), capA (OCM75), sak (OCM81), spa (OCM79), ilvD (OCM54), and 16S rRNA (OCD14 or OCD15).

CodY overexpression and purification.

The S. aureus CodY protein with five additional histidine residues appended to the C terminus was purified from Escherichia coli DH5α containing the pKM1 plasmid. To construct pKM1 (K. McKarty and A. L. Sonenshein, unpublished data), the codY gene was amplified from S. aureus genomic DNA (gDNA) by PCR with primers OKM1 and OKM2 (see Table S1) such that a SacI site, followed by the codY ribosome binding site, preceded the codY gene. The reverse primer incorporated the five additional histidine residues followed by a stop codon and an SphI site at the 3′ end of the gene. The resulting PCR product was cloned in pBAD30, placing the S. aureus codY gene under the control of the araBAD promoter (16). E. coli(pKM1) was grown to mid-exponential phase in Luria broth containing ampicillin (50 μg/ml) and then induced with 0.2% l-arabinose and incubated for 4 h. Cells were harvested by centrifugation, and the His6-tagged CodY protein was purified as previously described (44) using Talon Co2+ metal affinity resin (Novagen). The concentration of CodY was determined in a Bio-Rad assay using bovine serum albumin as the standard.

DNase I footprinting analysis.

Oligonucleotides OCM86 (for ilvD), OCM83 (for oppB), and OCM107 (for katA) were 5′ end labeled with radioactive [γ-32P]ATP (Perkin-Elmer) using T4 polynucleotide kinase (New England BioLabs, Inc.) according to the manufacturer's recommendations. The 32P-labeled primer was then purified with a QIAquick nucleotide removal kit (Qiagen). To generate the 32P-end-labeled promoter fragment for the footprinting reactions, the katA or oppB promoter was PCR amplified from UAMS-1 gDNA with 32P-labeled OCM107 and OCM108 or 32P-labeled OCM83 and OCM84, respectively. The ilvD promoter region was PCR amplified from pCM22 using 32P-labeled OCM86 and P-ilvD1. The ilvD region in pCM22 was generated by PCR amplification of SA564 gDNA using primers OCM86 and P-ilvD1 and introduced into the pCR2.1 TOPO vector according to the manufacturer's recommendations (Invitrogen). Following amplification of the 32P-end-labeled DNA fragment, 40,000 cpm of the end-labeled PCR product was used for each footprinting reaction. CodY was mixed at various concentrations (25 to 800 nM) with the 32P-end-labeled promoter DNA in binding buffer (20 mM Tris [pH 8.0], 50 mM KCl, 2 mM MgCl2, 5% glycerol, 0.5 mM EDTA, 1 mM dithiothreitol, 0.05% Nonidet P-40, 25 μg/ml calf thymus DNA). When indicated, 10 mM (each) isoleucine, leucine, and valine or 2 mM GTP or both were added. Binding reaction mixtures were incubated at room temperature for 20 min and digested for 30 s with 2 μl of RQ1 DNase I (Promega) containing 0.25 to 0.5 units of enzyme. DNase I digestion and sample purification were as described by Handke et al. (17). A sequence ladder was created using pCM22 or pCM24 DNA and the primers OCM86 or OCM88, respectively, using the Sequenase kit (USB) and [α-35S]dATP (Perkin-Elmer). The plasmid pCM24 was created by ligating the capA promoter (generated by PCR amplification of SA564 gDNA using primers OCM66 and OCM67) to the pCR2.1 TOPO vector according to the manufacturer's recommendations (Invitrogen). The pCM24 sequence (generated with OCM88) was run with the oppB and katA footprints.
DNase I digestion products and sequencing reaction products were separated on a denaturing 8 M urea-6% polyacrylamide gel by electrophoresis at 1,200 V for 2.5 h. The dried gel was exposed to a phosphor screen (Kodak) and analyzed with a Storm 820 scanner and software (Amersham Biosciences).

Primer extension analysis to map the transcriptional start site of ilvD.

Twenty micrograms of RNA isolated from exponentially growing cells of S. aureus strain NCTC 8325 and purified as described previously (28) was incubated with 5′-end-labeled oligonucleotide P-ilvD2 and SuperScript II reverse transcriptase (SSII; Invitrogen) according to the manufacturer's recommendations. The reverse transcription products were collected by precipitation with ethanol, redissolved, and separated on a denaturing 8 M urea-6% polyacrylamide gel as above. A sequencing ladder was prepared as described above using pCD2 as the template and P-ilvD2 as primer. The ilvD region in pCD2 was generated by PCR amplification of NCTC 8325 genomic DNA using primers P-ilvDseq and P-ilvD2 and cloning of the PCR product in the pCR2.1 TOPO vector.

Affinity purification of CodY-DNA complexes and analysis with the Illumina Genome Analyzer II.

Since the genome of UAMS-1 has not yet been sequenced, we used genomic DNA (two independent preparations) from the sequenced S. aureus strain NCTC 8325. Cells were scraped from a TSA plate grown overnight at 37°C, washed with 0.1 M NaCl, and lysed by incubation for 30 min at 37°C in 0.5 ml of Tris-EDTA containing 100 μg lysostaphin. After extraction with phenol-chloroform-isoamyl alcohol and ethanol precipitation, each DNA pellet was resuspended in 500 μl sterile deionized water and sheared by sonication (Branson 250 Sonifier with a microtip) to a fragment size of 300 to 1,000 bp by four 30-s sonication cycles on ice; each sonication cycle was separated by a 30-s incubation on ice. After addition of 10 μg of RNase A, the samples were incubated at 37°C for 20 min. The DNA was repurified by phenol-chloroform-isoamyl alcohol extraction and ethanol precipitation, resuspended in 100 μl 10 mM Tris-HCl (pH 8.0), 1 mM EDTA, and cleaned by using the Qiagen PCR purification kit, according to the manufacturer's recommendations. To create separately bar-coded DNA populations, four different bar-coded adapters were created. To do so, equal amounts of complementary oligonucleotides (e.g., BC1a and BC1b for bar code 1) were mixed and allowed to anneal by heating to 95°C and slow cooling to <40°C. (The b series of oligonucleotides were phosphorylated at the 5′ ends after synthesis.) Samples (5 μg) of blunt-ended gDNA were prepared by treatment with the Quick Blunting kit (New England BioLabs), according to the manufacturer's recommendations, followed by incubation at 75°C for 30 min. A dA residue was added to the 3′ end of each fragment by incubation with 1 μl of DNA polymerase I Klenow fragment (lacking exonuclease activity; New England BioLabs) and 0.5 μl dATP (100 mM) for 45 min at 37°C, followed by a 30-min incubation at 75°C. The sheared, blunt-ended DNA was then ligated to the bar-coded adapters (0.125 nmol per reaction mixture) using the Quick Ligation kit. Each bar-coded sample was run on a 2% agarose gel, and DNA bands corresponding to the range of 400 to 500 bp were recovered from the gel using the Qiagen QIAquick gel extraction kit. Each purified, bar-coded DNA sample was then split into seven aliquots, each of which was subjected to 15 cycles of PCR amplification using primers Olj139 and Olj140 (see Table S1 in the supplemental material). The seven reaction mixtures with the same bar code were pooled, extracted with phenol-chloroform-isoamyl alcohol, and precipitated with ethanol. Each DNA pellet was dissolved in 60 μl of sterile, deionized water and quantitated by measuring absorbance at 260 nm.
Fifty micrograms of bar-coded DNA, in a total volume of 250 μl, was then used in a binding reaction mixture with 200 nM purified His6-tagged S. aureus CodY or His-tagged B. subtilis aconitase (42) in a buffer containing 20 mM Tris-Cl (pH 8.0), 50 mM sodium glutamate, 10 mM MgCl2, 0.05% Nonidet P-40, 5% glycerol, and 25 μg/ml E. coli tRNA, supplemented with 10 mM (each) isoleucine, leucine, and valine (ILV) and 2 mM GTP. After gentle mixing at room temperature for 25 min, the sample was mixed with Talon Co2+ metal affinity resin (0.1-ml packed bed volume) that had been preequilibrated with the supplemented buffer. The resin was washed six times with 0.25 ml of supplemented buffer, resuspended in 100 μl of 10 mM Tris (pH 8.0), boiled for 5 min, and then incubated with proteinase K (100 μg/ml) for 2 h at 65°C, followed by boiling for 5 min. After centrifugation for 1 min at 3,000 × g, 100 μl of the supernatant fluid was purified by using a PCR purification kit (Qiagen) and then subjected to 10 cycles of PCR amplification with primers Olj139 and Olj140, repurified, quantified, and subjected to analysis with the Illumina Genome Analyzer II at the Tufts University Core Facility. Each affinity purification experiment was done in duplicate. Forty cycles of sequencing were performed for each fragment end. Sequence alignment and assembly were performed using MAQ (24) against the S. aureus NCTC 8325 complete genome sequence (NCBI accession number CP000253.1). Only valid pairs that contained no more than three mismatches with respect to the aligned sequence and had a paired insert size of less than 600 bases were included in the analysis. Using BioPerl scripts, a coverage value (corresponding to the number of sequenced overlapping DNA fragments at a given position) was generated for every position of the genome for each set, creating a coverage map for each sample. The CodY/aconitase (Acn) enrichment ratio at every position was then calculated. To eliminate bias due to differences in the number of mapped reads between samples, mapped reads were randomly discarded from the larger set until each had the same number. Regions of enrichment in the CodY sample were defined as sequences for which the CodY samples showed an average enrichment ratio greater than 5-fold over a length of more than 100 consecutive positions. The coverage maps were compared, and the R statistical computing environment was used to calculate the Pearson correlation coefficient for the CodY and Acn samples. The CodY samples had a correlation of 0.98, the Acn samples had a correlation of 0.97, and the CodY-Acn correlation values ranged from 0.24 to 0.27. The enrichment values (CodY/Acn) had a correlation of 0.84.
The nucleotide sequences from the enriched regions comparing bar codes 1 and 2 were used as a training set for finding motifs by using MEME 4.1.0 (1). We allowed MEME to find motifs that occurred zero times or once per fragment on either strand of DNA and that had a P value of ≤0.003. A script was created that searched for canonical CodY boxes using the consensus sequence AATTTTCWGAAAATT (12, 15), within the identified regions, allowing up to three mismatches.

Identification of a capA promoter binding protein.

Total cellular extract was isolated from lysostaphin-treated cells of an overnight culture of strain Becker as previously described (27). The protein extract was fractionated by ammonium sulfate precipitation. Precipitated protein fractions collected with 45% ammonium sulfate were dissolved and dialyzed overnight in Tris-EDTA (pH 7.5). The dialysate was applied to a G150 gel filtration column (45 cm by 1.7 cm) that had been equilibrated with Tris-HCl (pH 8.0) and 0.9% NaCl. Protein fractions (∼1 ml) were collected in the same buffer and quantified by bicinchoninic acid assay (Pierce). Each fraction was tested for binding to a [γ-32P]ATP-labeled 155-bp DNA fragment containing the capA promoter region amplified by PCR from strain Becker using primer pairs cp8gs3 and cp8gs6 (see Table S1 in the supplemental material). Fractions that caused a band shift were pooled and used in a large-scale gel shift assay. The shifted protein-DNA complex was extracted from the polyacrylamide gel, boiled for 5 min in SDS sample buffer, and resolved by SDS-PAGE. The gel was stained with SYPRO Ruby (Bio-Rad), and the prominent band corresponding to an apparent molecular mass of 29 kDa was excised and identified by mass spectrophotometric analysis.

Gel shift assay.

C-terminal His6-tagged CodY was purified on a nickel column (Novagen) and used in the gel shift assay. A 139-bp fragment containing the capA promoter was PCR amplified from strain Newman gDNA using primer pairs cp8gs6 and cp8gs15 and labeled using a digoxigenin labeling kit (Roche). The gel shift assay was carried out by mixing the probe (∼5 pM) with increasing amounts of CodY protein in a total reaction volume of 20 μl as previously described (35). For competition experiments, an unlabeled DNA fragment was used as a specific competitor, and a 161-bp DNA fragment containing the promoter of the 16S rRNA gene, amplified using primers P16S1 and P16S2, was used as a nonspecific competitor.

Microarray data accession number.

All of the microarray data used for this paper have been deposited in the GEO database ( ) under accession number GSE20973.


The CodY regulon of strain UAMS-1.

To assess the breadth of the CodY regulon in the S. aureus osteomyelitis isolate UAMS-1, RNA extracted from exponential- and post-exponential-phase cultures in TSB medium of UAMS-1 and its codY mutant, MS1, was subjected to microarray analysis. The concentration of CodY in exponential- and post-exponential-phase cultures is the same (28), but CodY was expected to be most active under conditions of nutrient excess. In fact, when exponential-phase samples were compared, 179 genes were more than 2-fold overexpressed (Table 2) and 24 genes were more than 2-fold underexpressed (Table 3) in the codY mutant, relative to its parent. For comparison, 106 genes were 2-fold overexpressed and 18 genes were 2-fold underexpressed in a codY mutant of strain Newman grown in a defined medium containing the BCAAs (38). Thus, S. aureus CodY, like B. subtilis CodY (31), acts predominantly as a negative regulator of transcription. In post-exponential phase, only 30 of the 109 genes that were differentially regulated in the codY mutant of UAMS-1 were overexpressed.
The CodY regulon of S. aureus has considerable overlap with the CodY regulons of B. subtilis (31), L. lactis (15), L. monocytogenes (4), S. pneumoniae (19), and C. difficile (S. S. Dineen, S. McBride, and A. L. Sonenshein, unpublished data), especially with respect to metabolic genes. For instance, in S. aureus, as in most of the other species, the genes encoding the enzymes of the BCAA biosynthetic operon (ilvDBNC leuABCD ilvA) and the biosynthetic pathways for certain other amino acids (cysteine, glutamate, histidine, serine, tryptophan, tyrosine, and the aspartate family amino acids [aspartate, lysine, threonine and methionine]) were overexpressed in the codY mutants of both UAMS-1 (Table 2) and Newman (38). Similarly, many genes encoding amino acid or peptide transporters, various permeases, and several peptidases were differentially regulated in the codY mutant of UAMS-1 compared to the parental strain (Table 2).
The members of the CodY regulon that are unique to S. aureus are primarily genes whose products have been linked to pathogenesis (Tables 2 and 3) (38). Our previous work identified the hla (alpha-toxin), ica (PIA synthesis), and agr loci as targets of negative regulation by CodY (28). A total of 50 genes associated with virulence were differentially expressed in the codY mutant of UAMS-1 during either the exponential or post-exponential growth phase. During exponential phase, 28 characterized or putative virulence genes, organized in 20 apparent transcription units, were overexpressed in the codY mutant of UAMS-1 (Table 2). These genes included agrA, hld, capACDFG, chp, efb, geh, hla, hlb, icaADBC, katA, geh, nuc, rot, sspB2, SA1971, and sodA, as well as other genes located within a pathogenicity island or that share similarity with characterized adhesins or phenol-soluble modulins. The genes capA- to -N, geh, katA, and hld, and a phenol-soluble modulin were also differentially expressed in the codY mutant of strain Newman (38). Semiquantitative RT-PCR analysis confirmed the transcription profiles of selected genes for UAMS-1 and its codY mutant and extended the findings to the clinical isolate SA564 and its codY mutant (see Fig. S1 in the supplemental material).

The role of agr in the CodY regulon of UAMS-1.

The effect of a codY mutation on the agr locus (40-fold) is much more severe in strains UAMS-1 and SA564 (Table 2 and reference 28) than in strain Newman (2- to 3-fold) (38). Since the basal level of agr expression during exponential growth seems to be higher in Newman than in UAMS-1 or SA564, the derepressing effect of a codY mutation may be less pronounced in Newman. It is not known what causes the strain-to-strain variability in the activity of the agr locus during exponential growth.
As the agr locus is a known regulator of virulence genes (6, 9, 14, 34), we sought to determine the extent to which the overexpression of virulence genes in the codY mutant was caused by increased transcription of the agr locus by comparing transcript levels in the isogenic strains UAMS-1, MS1 (ΔcodY::ermC), CM18 (Δagr::tetM), and CM19 (ΔcodY::ermC Δagr::tetM). (We made the assumption that an agr mutation has no effect on CodY function, since the level of the codY transcript was not affected by an agr mutation in strain UAMS-1 [data not shown].)
An agr mutation by itself resulted in no differences in the abundance of specific transcripts in exponential-phase cells, as previously reported (8). Moreover, comparison of transcript levels in the codY mutant and the agr codY double mutant showed that the agr locus has little impact on the expression of metabolic genes that are CodY regulated (Tables 2 and 3). Similarly, a group of virulence factors that includes katA, chp, efb, geh, icaADBC, nuc, rot, sspB2, SA0480 (a pathogenicity island gene encoding a hypothetical protein), and SA1164 (a gene encoding a fibrinogen binding-related protein) was altered in expression to essentially the same extent in both the codY mutant and the codY agr double mutant strains (relative to the wild-type parent) (Table 2). In strain Newman, the virulence-related genes katA and sodM and some genes of the cap locus were affected by a codY mutation in an agr mutant strain (38). We conclude that CodY regulates transcription of the majority of its regulon in an agr-independent manner.
However, for other members of the CodY regulon, including the virulence-associated genes capACDFG, hla, hlb, SA1186 (phenol-soluble modulin), and SA0270 (putative staphyloxanthin biosynthesis protein), the effect of a codY mutation was suppressed by an agr mutation (Table 2). That is, in the agr single mutant and in the agr codY double mutant, the transcript levels for these genes fell below (or were at) the limit of detection. These results suggest that CodY-dependent regulation of these genes is mediated primarily through the effect of CodY on the agr locus, but we cannot rule out the possibility that in the absence of positive regulation by the Agr system the level of transcription of these genes is so low that any independent effect of a codY mutation would be undetectable.

Role of sarA in codY-mediated overexpression of the agr locus and the ica locus.

Since SarA is a known activator of both the agr (10, 18) and ica loci (21, 48), we asked if CodY was acting through sarA to cause overexpression of some virulence genes. Semiquantitative RT-PCR analysis showed that RNAII and RNAIII were overexpressed in a codY mutant independently of the status of the sarA gene (Fig. 1A), but sarA may be needed for maximal expression of these genes. Similar analysis (Fig. 1B) showed that icaA was overexpressed in codY, agr codY, and agr sarA codY mutants, confirming and extending the microarray results and demonstrating that repression of the icaA promoter by CodY is independent of both SarA and RNAIII. Additionally, Fig. 1B shows that the abundance of icaR mRNA was unaffected by any of the mutations tested, a result consistent with our previous finding that the effect of a codY mutation on expression of the ica locus is independent of icaR transcript levels (28). During post-exponential growth, the icaA transcript levels in all strains were at similarly low, undetectable levels (data not shown).

Genome-wide identification of CodY binding sites in S. aureus.

To determine the direct targets of CodY, we designed an affinity purification (pull-down) experiment using purified His6-tagged S. aureus CodY to identify all regions of the S. aureus genome that interact with CodY in vitro. gDNA from the S. aureus strain NCTC 8325 was used in the pull-down experiment because the genome of this strain has been fully sequenced, a prerequisite for effective resequencing using the Illumina Genome Analyzer II (GA II). The protocol for this experiment is outlined in Fig. 2. Binding reactions were carried out with 200 nM His6-tagged S. aureus CodY, a fragmented, adapter-ligated gDNA library, and a buffer containing the effectors of CodY activity (10 mM ILV and 2 mM GTP). A control pull-down experiment with 200 nM purified His-tagged B. subtilis aconitase (Acn) was carried out in parallel. The DNA-protein complexes were isolated from solution using a Co2+ resin, amplified, and subjected to high-throughput paired-end sequencing. That is, the sequences of the first and last ∼40 bp of each DNA fragment were determined directly. Then, for each fragment, the sequence between the fragment ends was filled in based on the published sequence of the NCTC 8325 genome. In this way, a coverage map of the entire genome in each purification experiment was created. The coverage map represents the number of times a specific base pair on the chromosome is represented in the sequencing of each DNA sample. An enrichment value was then generated for every position on the chromosome by comparing the coverage map of the CodY pull-down assay to the coverage map of the Acn pull-down assay. Enriched regions were arbitrarily defined as regions longer than 100 bp that showed 5-fold or higher enrichment throughout their length in the CodY pull-down assay relative to the Acn pull-down assay. From this collection of regions, a subset in which the position (bp) of maximum enrichment in the CodY sample was 20-fold or higher was selected for further analysis. Table S4 in the supplemental material lists all 231 positions of high enrichment that were identified, the maximum enrichment value found in that region, the local gene structure near the position of enrichment in NCTC 8325, and the corresponding annotation and gene function. Fifty-eight percent (134/231) of the positions of maximal enrichment mapped to intergenic regions. In the NCTC 8325 genome, as well as many other S. aureus genomes, only 15% of the nucleotides map to intergenic regions ( ). Thus, CodY binding sites show a preference for intergenic regions compared to coding sequences.
Using the MEME suite ( ), we found a 21-bp conserved motif (referred to here as the de novo motif) (Fig. 3) in 223 of the 231 regions of high enrichment. A 15-bp conserved sequence (the canonical CodY box, AATTTTCWGAAAATT) was previously described based on analysis of L. lactis and B. subtilis CodY-regulated genes (3, 12, 15). The canonical CodY box is contained almost completely within the de novo motif (Fig. 3). The enriched regions were also searched for the previously described CodY binding box, allowing up to three mismatches. The locations of the first nucleotide of each 21-bp de novo (i.e., newly identified) motif and of each 15-bp CodY box, relative to the position of maximal enrichment, are shown in Table 4 and in the supplemental information. Ninety-seven CodY boxes were found within the enriched regions and usually overlapped with the newly identified motifs.
We also asked whether the enriched positions were near genes whose expression is affected by a codY mutation. Of the 231 enriched positions, 63 fell within or upstream of genes that were overexpressed in the codY mutant of UAMS-1, and 9 were associated with genes that were underexpressed in the codY mutant. The 59 enriched positions that corresponded to genes regulated by CodY during the exponential growth phase mapped to a total of 49 transcriptional units that are strong candidates for direct regulation by CodY (Table 4). Ninety-six percent (56/59) of the enriched regions that are associated with genes regulated by CodY during exponential growth have a newly identified motif. Sixty-two percent of these regions of enrichment have at least one CodY box, which is always in close proximity to, if not overlapping the location of, a newly identified motif. Interestingly, the de novo motif is not symmetrical and is therefore specific to one strand, whereas the CodY box is palindromic.
Based on this analysis, many genes that are strong candidates for direct repression by CodY are involved in amino acid biosynthesis or macromolecular transport (Table 4). In addition, nine transcription units associated with virulence are likely to be directly regulated by CodY. The promoter regions of hlb, hla, SA1164 (encoding a fibrinogen binding-related protein), and SA2419 (encoding IgG-binding protein SBI) were bound by CodY in vitro and repressed by codY in vivo. In the case of hla, which encodes alpha-toxin, the site of maximum enrichment in the CodY pull-down assay lies about 700 bp upstream of the transcriptional start site; this site corresponds to the location of a CodY box (with three mismatches) and a de novo motif. The hlb gene, encoding beta-toxin, has a CodY box (with three mismatches) located 319 bp upstream of the translational start site at a position that corresponds to a determined site of maximum enrichment (Table 4). Interestingly, the hla gene is subject to regulation by the Agr system; the impact of a codY mutation was lost in an agr mutant. The fact that hla appears to be a direct target of CodY binding suggests that hla is subject to two forms of regulation, positive regulation mediated by RNAIII and negative regulation by CodY.
One position of maximum enrichment corresponds to a gene that was underexpressed in a codY mutant during exponential growth. This gene, SA1042, encodes a hypothetical protein of unknown function with homologs present only in other S. aureus strains. SA1043, which encodes a glycosyltransferase group I family protein, is immediately downstream of SA1042 and is probably within the same transcription unit. Both SA1042 and SA1043 were underexpressed in the codY mutant during exponential growth. This operon may be the only example in S. aureus of direct positive regulation by CodY during the exponential growth phase. Surprisingly, the region of enrichment associated with SA1042 does not contain a canonical CodY box (with fewer than five mismatches), but it does contain a newly identified motif.
Nine positions of enrichment are associated with genes underexpressed in the codY mutant during post-exponential growth and include positions near the following genes: SA1042, purQ, SA0788, SA2309, SA1883, SA1664, SA0088, SA0662, SA1042, and SA1883. Three enriched regions are associated with genes overexpressed in the codY mutant during post-exponential growth and include positions near capK, SA2491 (a conserved hypothetical protein), and sspB1 (a cysteine protease precursor). The fact that the expression of some genes that appear to be direct targets of CodY is only affected by a codY mutation in post-exponential-phase cells, i.e., in cells in which CodY is expected to be inactive even in the wild-type strain, has two implications. First, such genes are probably not affected by a codY mutation during exponential growth because of overriding regulation by other factors. Second, CodY must retain some activity in wild-type post-exponential-phase cells.
Additionally, a considerable number of enriched regions were identified within or near genes whose transcript abundance is not affected by a codY mutation in UAMS-1. This list includes sasG, several surface proteins (including isaB, clfB, and ebh), and numerous other genes (for a complete list, see Table S4 in the supplemental material). The failure to observe in vivo CodY-mediated regulation near in vitro CodY targets can be due to several factors, including the activities of other regulators at a given locus and the genetic variation in S. aureus isolates. For instance, Pohl et al. recently reported that a codY mutation in strain Newman causes underexpression of the sasG gene during exponential growth (38). Moreover, the CodY pull-down experiment identified a position of maximum enrichment within the sasG gene of NCTC 8325. Because the UAMS-1 genome lacks the region (RD5) that contains the sasG gene (7), the sasG gene did not show up among those affected by a codY mutation in that isolate.

CodY-dependent regulation of the agr locus.

Although a codY null mutation clearly causes overexpression of the agr locus in strains UAMS-1, SA564 (28), and Newman (38), gel mobility shift analysis showed only a low-affinity interaction of CodY with the P2 and P3 promoter regions of the agr locus, which drive expression of all agr genes (data not shown), and the CodY pull-down experiment did not show any significant enrichment of the P2-P3 region. The CodY pull-down assay, however, did show binding of CodY to the agrC gene (Table 3). When the agr locus was first described, a weak promoter (termed P1) was detected in this region through a gene fusion with a promoterless lacZ gene (36). Thus, CodY may directly regulate the P1 promoter of the agr locus or block elongation of transcripts from the major P2 promoter upstream of agrB. Future work will be directed toward understanding how the agr locus is regulated by CodY.

CodY binding sites in the ilvD promoter region.

Because the ilvD promoter has two CodY boxes (11, 38), was overexpressed in codY mutants of strains Newman (38), UAMS-1, and SA564, and was enriched in the pull-down assay, it is very likely to be a direct CodY target. To confirm such an interaction, we used DNase I footprinting analysis to locate the CodY binding sites(s) within the ilvD promoter region. As shown in Fig. 4, we found two high-affinity binding sites that correlated well with the positions of the CodY boxes. Moreover, the binding sites defined by footprinting analysis overlapped with the region enriched in the pull-down experiment (Fig. 4B). Primer extension analysis was used to map the 5′ end of the ilvD mRNA (Fig. 4B and data not shown). The apparent transcriptional start site of the ilvD promoter fell between the two sites of CodY binding. Given that the ilv operon is strongly overexpressed in a codY mutant, the sequence-specific binding of CodY leads us to conclude that ilvD is directly repressed by CodY.

S. aureus CodY is activated synergistically by the BCAAs and GTP.

CodY proteins from B. subtilis (17, 43), C. difficile (13), and L. monocytogenes (4) are activated as DNA binding proteins by the BCAAs and GTP. The CodY proteins of L. lactis and S. pneumoniae, however, are only activated by the BCAAs (19, 37). To test the response of S. aureus CodY to these metabolites, we measured binding to the ilvD promoter in the absence of effectors or in the presence of 2 mM GTP or 10 mM ILV or both. When GTP and BCAAs were both present, CodY bound to the ilvD promoter with high affinity (50% protection was seen at 25 to 50 nM CodY). When either the BCAAs or GTP was absent, the affinity was greatly reduced but still higher than that of CodY alone (compare protection levels seen at 800 nM CodY with and without effectors).

CodY binding sites in the oppB and katA promoters.

Footprinting analysis was also used to locate the sites of CodY interaction with the promoter regions of oppB and katA. CodY bound to the oppB promoter at a position that overlaps with both a CodY box and the sequence enriched in the pull-down experiment (Fig. 5A). Similarly, CodY interacted with the katA promoter in a region that includes a CodY box (with three mismatches) and overlaps with the region enriched in the pull-down experiment (Fig. 5B). Binding of CodY was enhanced in the presence of the BCAAs and GTP (Fig. 5B). The footprinting experiment provides strong evidence that the katA promoter region is a direct target of CodY even though the maximum enrichment in the pull-down experiment was only 9-fold. Moreover, expression of the katA gene was derepressed by a codY mutation in both agr wild-type and mutant backgrounds.

The cap locus.

Pohl et al. (38) reported that the cap genes of strain Newman, which are responsible for capsule biosynthesis (25, 35), are regulated by CodY in both agr-positive and agr-negative strains, indicating that in strain Newman CodY regulates the cap locus through an agr-independent mechanism. The capA promoter has a CodY box that overlaps with the −10 region of the promoter (35, 38), reinforcing the likelihood that CodY directly regulates this operon.
Strong evidence that CodY directly represses the capA promoter of strain Newman came from experiments designed to identify in an unbiased way proteins that bind to the promoter. Protein extracts were partially purified by differential ammonium sulfate precipitation and then fractionated by gel filtration chromatography. Each fraction of the elution was tested for binding to the capA promoter by using a gel mobility shift assay. Fractions that caused a change in mobility of a capA promoter probe were pooled and used in a large-scale gel shift experiment. Two large bands corresponding to the shifted probe (Fig. 6A) were excised and subjected to SDS-PAGE analysis (Fig. 6B). A major protein band of about 29 kDa was detected after staining with SYPRO Ruby and transferred to a polyvinylidene difluoride membrane for N-terminal sequencing. The resulting sequence identified CodY as the major component of this sample. Gel shift analysis with purified CodY-His6 showed that CodY bound with high affinity to a 139-bp fragment containing the capA promoter. A complete shift occurred between 10 and 100 nM CodY (Fig. 6C). The shifted bands were competed away with a 1,000-fold excess of specific, cold competitor (the same 139-bp fragment from the capA promoter region), but not with a similar excess of nonspecific cold competitor (the promoter of the 16S rRNA gene) (Fig. 6C).
Despite the clear interaction of CodY with the capA promoter of strain Newman, the cap operon of strain UAMS-1 was overexpressed in exponential-phase cells of the codY mutant (Table 1), but not in strains lacking the agr locus (CM18 or CM19). Thus, the overexpression of the agr locus in the UAMS-1 codY mutant is at least partially responsible for the effect of a codY mutation on cap operon expression, in keeping with the fact that agr is known to activate cap transcription (26). Our data, however, did not allow us determine whether in UAMS-1 CodY has any effect on cap operon expression that is independent of agr, because the level of expression in the agr mutant was below detection. Interestingly, the capA promoter region of strain NCTC 8325 was not enriched in the CodY pull-down experiment, but two other regions within the cap operon, including sites within capD and capK, were enriched in the pull-down experiment (Table 4). Perhaps in NCTC 8325 and UAMS-1 CodY regulates one of the previously identified, internal promoters of the capA-P operon (41), or it might regulate this locus by blocking elongation of transcription from the capA promoter.


The present study, in conjunction with previous findings reported by Pohl et al. (38), shows that CodY directly or indirectly regulates more than a hundred genes in S. aureus. Many of these genes encode enzymes of amino acid biosynthesis, amino acid and peptide transport, and other nutrient transporters and show considerable overlap with members of the CodY regulons of other bacteria. By integrating in vivo expression data and in vitro DNA binding results, we have identified a number of genes for which CodY most likely acts as a direct repressor of transcription under conditions of nutrient excess.
CodY also regulates central metabolic pathways that determine the synthesis and distribution of pyruvate and 2-oxoglutarate, including the conversion of 2-oxoglutarate to glutamate, the step that couples carbon and nitrogen metabolism. The central metabolic pathways that appear to be directly regulated by CodY are depicted in Fig. 7. S. aureus encodes three lactate dehydrogenases, ldh1, ldh2, and ldh3 (40), that can, in principle, interconvert pyruvate and lactate. The conversion of pyruvate to lactate regenerates NAD+ from NADH; the reverse reaction allows lactate to be utilized as a carbon source. Interestingly, strains lacking ldh1 are attenuated in virulence, and strains lacking both ldh1 and ldh2 are nearly avirulent (40), linking pathogenesis to central metabolism. Since ldh1 is a direct target of repression by CodY, the product of ldh1 is likely to serve primarily as a lactate utilization enzyme.
Of the many S. aureus virulence factor genes whose expression is affected by a codY mutation in strains UAMS-1, SA564, and Newman (28, 38), about half are overexpressed in a codY mutant strain mostly, if not solely, because they are positively regulated by the Agr system and CodY is a repressor of the agr locus. A second large group of virulence genes and operons that is regulated by CodY independently of agr includes icaADBC, ldh1, isdF, sodA, SA2585, chp, geh, katA, nuc, rot, sspB2, SA1971, SA0480, SA1164, SA2418, rsbU, lytS, SA2294, SA2295, and SA0901.
The distinction between genes repressed by CodY through its effects on the agr locus and genes repressed directly by CodY is not always strict (Fig. 8). That is, some genes appear to be regulated by CodY both directly and indirectly. For instance, in both UAMS-1 and Newman, a codY mutation causes overexpression of cap operon genes during the exponential growth phase, and this overexpression is at least partially attenuated in an agr codY double mutant (this work and reference 38), consistent with the observation that the capA promoter is activated by RNAIII (26). However, during the exponential phase in strain Newman and in post-exponential phase in UAMS-1, the cap genes are significantly derepressed in the agr codY double mutant compared to an agr single mutant. Taken together, the data from UAMS-1 and Newman suggest that codY represses some genes of the cap locus through both agr-independent and agr-dependent mechanisms. Moreover, our results demonstrate that CodY binds to the capA promoter region of strain Newman and to sites within the cap operon in strain NCTC 8325.
Two other virulence genes that appear to be direct targets of CodY, sodA and katA, encode superoxide dismutase and catalase, respectively, which neutralize superoxides and hydrogen peroxide generated by reactive oxygen bursts produced by the host immune system. Evidence for direct repression by CodY is especially strong for the katA promoter, since footprinting analysis showed that CodY binds with high affinity to the katA promoter close to the position of maximum enrichment in the pull-down experiment. Positions of high enrichment were also found in or upstream of the virulence genes hla, hlb, sspB1, SA1164, SA2418, SA2585, and sasG. The hla (alpha-toxin) gene is interesting because its mRNA is dependent on RNAIII for translation and the gene is repressed by CodY at the level of transcription. SA2585, which encodes a putative member of the PfoR superfamily and has homologs in many Staphylococcus species, was overexpressed in codY mutants of both UAMS-1 (Table 2) and Newman, in which it was annotated as a hypothetical protein (38); this derepression is independent of the agr locus. It would be very interesting to determine the role of this transcriptional regulator in S. aureus and whether it contributes to the expression of genes of the CodY regulon.
Although CodY strongly represses the agrBDCA locus during exponential growth, we still do not know the exact mechanism of CodY regulation at this locus. In vitro binding assays show that CodY does not interact with the P2/P3 promoter region but instead binds within the agrC gene. One interpretation of these data presupposes that promoter P1, which lies near the end of agrC but has not been precisely mapped, is necessary for synthesis of a basal level of AgrA (the response regulator), without which the quorum-sensing system cannot respond to its peptide signal. Repression of P1 by CodY prevents any signal transduction when cells are in a nutrient-replete environment. Alternatively, CodY may achieve the same effect by acting as a transcription roadblock for mRNA initiated at P2. The two models are not mutually exclusive. Future work is aimed at addressing the role of the P1 promoter in CodY regulation of the agr locus. The presence of apparent CodY binding sites within other operons, such as the cap and ica operons, may also reflect roadblock mechanisms of regulation.
Many virulence determinants in S. aureus and other pathogens can be viewed as an extension of the stationary-phase response characteristic of many bacteria, including both pathogens and nonpathogens. That is, many bacterial pathogens induce the production of virulence factors under conditions of nutrient limitation and environmental stress, in conjunction with other stationary-phase-associated adaptive responses. In many cases, the benefit to the bacterium may be its more effective competition for limited nutrients. In S. aureus, as in other Gram-positive species, the CodY protein, through its monitoring of intracellular metabolite pools, appears to link the expression of many virulence genes to the control of central metabolic pathways and to the nutritional status and metabolic potential of the cell.
FIG. 1.
FIG. 1. Effects of sarA and agr mutations on CodY-regulated genes. (A) Transcripts corresponding to RNAIII, RNAII, and 16S rRNA were analyzed by RT-PCR from samples extracted during exponential (E) and post-exponential (P) phases of the wild-type (WT) and mutant strains of UAMS-1, as indicated. (B) Transcripts corresponding to icaA, icaR, and 16S rRNA were analyzed by RT-PCR from samples extracted from exponential-phase cells of the WT and mutant strains of UAMS-1, as indicated.
FIG. 2.
FIG. 2. Protocol for genome-wide identification of CodY binding sites. Briefly, gDNA was sheared by sonication. Adapters were ligated to the sheared DNA and then gel purified to obtain a DNA library containing fragments of 400 to 500 bp in length. The DNA library was then subjected to PCR amplification using adapter-specific primers to generate enough DNA for the pull-down experiment. A 200 nM concentration of His-tagged CodY or 200 nM His-tagged Acn was incubated with 50 μg sheared, adapter-ligated DNA and the effector molecules (2 mM GTP and 10 mM ILV). Protein-DNA complexes were purified with a Co2+ resin. Following elution of the protein from the resin, the DNA was isolated, PCR amplified again, and subjected to analysis with a Illumina Genome Analyzer II.
FIG. 3.
FIG. 3. S. aureus CodY binding motif. A search for common motifs in the 231 regions enriched in the CodY pull-down experiment was conducted using the MEME suite and the parameters described in Materials and Methods. The motif shown was found in 223 of the 231 enriched regions, with a P value ≤0.003. The canonical CodY box previously identified (12, 15) is shown below the S. aureus de novo binding motif for reference.
FIG. 4.
FIG. 4. Analysis of the ilvD promoter region. (A) DNase I footprinting analysis of CodY binding to the ilvD promoter in the presence and absence of 10 mM ILV (isoleucine, leucine, and valine) or 2 mM GTP or both. The concentration of CodY used in each reaction mixture is listed above each lane. (B) Annotation of the ilvD promoter sequence. Nucleotides in bold type represent DNA that was protected by CodY in the footprinting analysis. Predicted CodY binding sites are indicated (the canonical CodY box, AATTTTCNGAAAATT, is underlined, and the de novo motif is indicated in italics). The nucleotide in gray represents the position of maximal enrichment (89-fold) in the ilvD promoter, as determined in the CodY pull-down experiment. The apparent transcriptional start site mapped by primer extension lies 336 nucleotides upstream of the ilvD start codon and is indicated as a lowercase letter.
FIG. 5.
FIG. 5. Analysis of the katA and oppB promoter regions. (A) DNase I footprinting analysis of CodY binding to the oppB promoter in the presence of 10 mM ILV and 2 mM GTP. (B) Footprinting analysis of CodY binding to the katA promoter in the presence or absence of 10 mM ILV and 2 mM GTP. The concentration of CodY used in each reaction mixture is listed above each lane. The corresponding transcriptional unit and promoter sequence are shown below each footprint. In each case, predicted CodY binding sites are indicated (the canonical CodY box, AATTTTCNGAAAATT, is underlined, and the de novo motif is indicated in italics), the sequence corresponding to the region of protection by CodY in the footprinting analysis is shown in bold, and the position of maximum enrichment (54-fold for oppB and 9-fold for katA) defined by the CodY pull-down experiment is indicated by the gray nucleotide.
FIG. 6.
FIG. 6. CodY binding to the capA promoter. (A) Gel shift analysis of the capA promoter from strain Newman. (B) The protein-DNA complexes associated with both shifted bands were extracted and subjected to SDS-PAGE analysis. (C) A fragment of the capA promoter region from strain Newman was tested for binding to purified S. aureus CodY by gel shift analysis. CodY binding reactions were also carried out in the presence of 100 nM CodY and nonspecific (a 161-bp fragment of the 16S rRNA promoter region) or specific (the wild-type [WT] capA promoter) cold competitors.
FIG. 7.
FIG. 7. Genes of central metabolism that are direct targets of S. aureus CodY. The genes and operons that are direct targets of CodY are shown in italics and in association with the pathways they encode. Each gene or operon is preceded by an arrow that indicates whether the gene is repressed (downward pointing) or activated (upward pointing) by CodY. TCA, tricarboxylic acid; CoA, coenzyme A.
FIG. 8.
FIG. 8. Direct and indirect effects of CodY on S. aureus virulence gene expression. Genes shown in boldface are direct targets of CodY-mediated regulation, based on in vitro CodY binding. Connecting lines indicate whether CodY (or an agrBCDA product) regulates these genes negatively (T-junction) or positively (arrowhead). Genes regulated by CodY indirectly through its effect on the agr locus or on other, unknown regulatory genes are shown in normal typeface.
TABLE 1. Strains and plasmids used in this study
Plasmid or strainRelevant genotype and/or characteristic(s)Source or reference
    pCR2.1 TOPOCloning vectorInvitrogen
    pCM22pCR2.1 TOPO containing ilvD promoter from SA564This study
    pCD2pCR2.1 TOPO containing ilvD promoter from NCTC 8325This study
    pCM24pCR2.1 TOPO containing capA promoter from SA564This study
    pBAD30Expression vector with araBAD promoter16
    pKM1pBAD30 with S. aureus codY with five additional histidine codons at the C terminusMcCarty and Sonenshein, unpublished
S. aureus strains  
    UAMS-1Clinical isolate14
    MS1UAMS-1 ΔcodY::ermC28
    SA564Clinical isolate45
    CDM7SA564 ΔcodY::ermC28
    RN6911RN690 Δagr::tetM49
    CM18UAMS-1 Δagr::tetMThis study
    CM19UAMS-1 ΔcodY::ermC Δagr::tetMThis study
    UAMS929UAMS-1 sarA::kan5
    CM20UAMS-1 sarA::kanThis study
    CM21UAMS-1 Δagr::tetM sarA::kanThis study
    CM22UAMS-1 ΔcodY::ermC sarA::kanThis study
    CM23UAMS-1 ΔcodY::ermC Δagr::tetM sarA::kanThis study
TABLE 2. Select genes that are overexpressed in the codY mutant of UAMS-1
Gene group and annotationaGeneGenetic organizationbAssignmentcExpression ratio    
    Expd Pxpe  
    codYagr codYcodYagragr codY
Amino acid biosynthesis        
    Aspartate family        
        SA1360thrAthrAAspartate kinase54.237.8   
        SA1362homSA1361, hom, thrCB, SA1365Homoserine dehydrogenase45.336.2   
        SA1363thrC Threonine synthase51.433.5   
        SA1364thrB Homoserine kinase54.641.4   
        SA1365  Hydrolase, haloacid dehalogenase-like family5.84.5   
        SA1428lysClysC, asd, dapABD, SA1433, dal, lysAAspartokinase, alpha- and beta- subunits21.912.9   
        SA1429asd Aspartate-semialdehyde dehydrogenase2721.3   
        SA1430dapA Dihydrodipicolinate synthase28.820.3   
        SA1431dapB Dihydrodipicolinate reductase28.519.4   
        SA1432dapD 2,3,4,5-Tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase24.917.1   
        SA1433  Peptidase, M20/M25/M40 family16.811.7   
        SA1434Da Alanine racemase family protein12.710.2   
        SA1435lysA Diaminopimelate decarboxylase74.3   
        SA0012 SA0012Homoserine O-acetyltransferase6.85.3   
        SA1477ilvA1ald1, ilvA1, SA1476, SA1475Threonine dehydratase, catabolic4.4    
        SA2042ilvDilvDBHC, leuABCD, ilvADihydroxy-acid dehydratase202144.6   
        SA2043ilvB Acetolactate synthase, large subunit, biosynthetic type233.2155   
        SA2044ilvN Acetolactate synthase, small subunit, truncation489.9353.2   
        SA2045ilvC Ketol-acid reductoisomerase236.3189.7   
        SA2046leuA 2-Isopropylmalate synthase190.4143.1   
        SA2047leuB 3-Isopropylmalate dehydrogenase145.6123.1   
        SA2048leuC 3-Isopropylmalate dehydratase, large subunit117.699.1   
        SA2049leuD 3-Isopropylmalate dehydratase, small subunit157.3153.2   
        SA2050ilvA Threonine dehydratase46.848.8   
        SA0600ilvEilvEBCAA aminotransferase6.24   
        SA0431 SA0431, SA0430, SA0429, metE, SA0427trans-Sulfuration enzyme family protein86.253.7   
        SA0430  trans-Sulfuration enzyme family protein89.460.1   
        SA0429  5-Methyltetrahydrofolate-homocysteine methyltransferase, putative88.6572.8  
        SA0428metE 5-Methyltetrahydropteroyltriglutamate-homocysteine methyltransferase4829.42.4 2.7
        SA0427  Conserved hypothetical protein21.112.9   
        SA0870 SA0870LysE/YggA family protein7.56   
        SA2575 SA2575, 2574Aspartate aminotransferase, class I10.56.8   
        SA2574  d-Isomer-specific 2-hydroxyacid dehydrogenase family protein7.94.3   
        SA2704hisZhisZGD, SA2701, BHAFIConserved hypothetical protein17.311   
        SA2703hisG ATP phosphoribosyltransferase7.55.3   
        SA2702hisD Histidinol dehydrogenase13.87.8   
        SA2700hisB Imidazole glycerol phosphate dehydratase6.4    
        SA2699hisH Imidazole glycerol phosphate synthase, glutamine amidotransferase subunit4.12.9   
        SA2698hisA Phosphoribosylformimino-5-aminoimidazole carboxamide ribotide isomerase11.87   
        SA2697hisF HisF protein (cyclase)8.45.8   
        SA2696hisI Phosphoribosyl-ATP pyrophosphatase/phosphoribosyl-AMP cyclohydrolase6.94.8   
        SA0784hisChisCHistidinol-phosphate aminotransferase7.36   
        SA1772 SA1772, serAAminotransferase, class V67.739.7   
        SA1773serA d-3-Phosphoglycerate dehydrogenase72.144.3   
        SA1774 SA1776-SA1774Hydrolase, haloacid dehalogenase-like family9.78.4   
    Aromatic amino acids        
        SA1403trpEtrpEGDCFBAAnthranilate synthase component I2.9    
        SA1406trpC Indole-3-glycerol phosphate synthase34.627.5   
        SA1407trpF N-(5-Phosphoribosyl)anthranilate isomerase21.816.9   
        SA1408trpB Tryptophan synthase, beta subunit28.219.93  
        SA1409trpA Tryptophan synthase, alpha subunit8.35.6   
        SA1505aroBaroCBA, SA1503-SA15003-Dehydroquinate synthase3.22.9   
        SA1504aroA 3-Phosphoshikimate 1-carboxyvinyltransferase2.82.7   
        SA1787 SA1787Chorismate mutase/phospho-2-dehydro-3-deoxyheptonate aldolase5.84.4   
        SA0514gltBgltBDGlutamate synthase, large subunit41.738   
        SA0515gltD Glutamate synthase, small subunit2822.5   
        SA1401tyrAtyrAPrephenate dehydrogenase9.66.8   
        SA1074purKpurEKCSQLFMNHDPhosphoribosylaminoimidazole carboxylase, ATPase subunit2.73.3   
        SA1075purC Phosphoribosylaminoimidazole-succinocarboxamide synthase4.95   
        SA1076purS Phosphoribosylformylglycinamidine synthase4.55.9   
        SA1077purQ Phosphoribosylformylglycinamidine synthase I6.77.3   
        SA1078purL Phosphoribosylformylglycinamidine synthase II4.75.5   
        SA1079purF Amidophosphoribosyltransferase5.56.7   
        SA1080purM Phosphoribosylformylglycinamidine cyclo-ligase5.26.8   
        SA1081purN Phosphoribosylglycinamide formyltransferase5.16.2   
        SA0925purH Phosphoribosylamine-glycine ligase5.35.6   
        SA1083purD Phosphoribosylaminoimidazole carboxylase, ATPase subunit5.35   
    Amino acid and peptide transport        
        SA0185 SA0185, SA0186, SA0187, ggtPeptide ABC transporter, permease protein28.725.5   
        SA0186  Peptide ABC transporter, permease protein29.626.812.3 13.8
        SA0187  Hypothetical protein29.423.2   
        SA0188ggt Gamma-glutamyltranspeptidase15.712.19.2 8
        SA0991oppBoppBCDF, SA0995Oligopeptide ABC transporter, permease protein35.925.9   
        SA0992oppC Oligopeptide ABC transporter, permease protein44.335.2   
        SA0993oppD Oligopeptide ABC transporter, ATP binding protein42.632.1   
        SA0994oppC Oligopeptide ABC transporter, ATP binding protein5.45.3   
        SA0995  Oligopeptide ABC transporter, oligopeptide binding protein52.948.3   
        SA2476 SA2476-SA2471Peptide ABC transporter, peptide-binding protein3.52.5   
        SA0302brnQ2brnQ2-0303BCAA transport system II carrier protein8.95.8   
        SA0171brnQ1brnQ1BCAA transport system II carrier protein10.98.5   
        SA2619 SA2619Amino acid permease61.648.1   
        SA1963 SA1963Proline permease4.83.1   
        SA0010 SA0010, SA0011AzlC family protein7.24.8   
        SA0011  Conserved hypothetical protein13.911.7   
        SA0228 SA0228-SA0232Transcriptional antiterminator2.71.7   
        SA0230  PTS system, sorbitol-specific IIB component2.91.4   
Other transporters        
        SA0882 SA0882-SA0884ABC transporter, ATP binding protein6.84.8   
        SA0883  ABC transporter, permease protein7.75.7   
        SA0884  ABC transporter, substrate binding protein9.58   
        SA0504 SA0504-SA0506ABC transporter, ATP binding protein42.841.1   
        SA0505  ABC transporter, permease protein49.848.4   
        SA0506  ABC transporter, substrate binding protein46.448.1   
        SA1018 SA1018-1019Sodium:alanine symporter family protein41.933.3   
        SA1019  Conserved hypothetical protein8.37.4   
        SA1038 SA1038-SA1040Membrane protein2620.9   
        SA1039  Conserved hypothetical protein10.29.8   
        SA1040  ABC transporter, ATP binding protein15.912.4   
        SA2144 SA2144-SA2143ABC transporter, ATP binding protein6.96.5   
        SA2314 SA2314-SA2312Sodium/bile acid symporter family protein12.710.8   
        SA2312  Conserved hypothetical protein4.63.6   
        SA2525 SA2525, SA2526ABC transporter, ATP-binding protein87.7   
        SA1144isdFisdCDEF, srtB, isdGIron compound ABC transporter  2.4 2.4
        SA2483 SA2483Transporter, putative9.95.9   
        SA0126 SA0127-SA0125Phosphonate ABC transporter, permease protein3.01.9   
        SA0128 SA0128Phosphonate ABC transporter, phosphonate binding protein3.32.4   
        SA0267 SA0267-SA0264Hypothetical protein6.14.6   
        SA0264  ABC transporter, ATP binding protein3.62.7   
        SA0303 SA0303Hypothetical protein, similar to sodium-coupled permease4.33.1   
        SA1963  Proline permease4.83.1   
Krebs cycle and carbon overflow        
    SA1123pycpycPyruvate carboxylase5.94.3   
    SA1449sucAsucAB2-Oxoglutarate dehydrogenase, E1 component4.63.4   
    SA1448sucB 2-Oxoglutarate dehydrogenase, E2 component3.52.6   
    SA0222ldh1ldh1l-Lactate dehydrogenase  22.9 11.7
Environmental stress response        
    SA0118sodAsodASuperoxide dismutase5.84.2   
    SA2641gpxA2gpxA2Glutathione peroxidase6.75.4   
    SA2585 SA2585Regulatory protein, putative133.288.4   
    SA0767 SA07607, saeRS 4.83.2   
    SA0765saeS Sensor histidine kinase SaeS2.4    
Virulence factors        
    SA2026agrAagrBDCAAccessory gene regulator protein A6.4    
    SA0136cap5AcapABCDEFGHIJKLMNOPCapsular polysaccharide biosynthesis5.5  0.11 
    SA0138cap5C Capsular polysaccharide biosynthesis5.2  0.21 
    SA0139cap5D Capsular polysaccharide biosynthesis5.7  0.16 
    SA0141cap5F Capsular polysaccharide biosynthesis5  0.18 
    SA0142cap5G UDP-N-acetylglucosamine 2-epimerase4.1  0.23 
    SA0148cap5 M Galactosyltransferase  3.90.27 
    SA0149cap5N Capsular polysaccharide biosynthesis  3.7  
    SA0151cap5P UDP-N-acetylglucosamine 2-epimerase  2.6  
    SAR2036chpchpChemotaxis-inhibiting protein, MRSA25221.716.9   
    SA1168efbefbFibrinogen binding protein8.28.5   
    SA2694gehgeh, SACOL2693Glycerol ester hydrolase10.35 0.070.09
    SA1173hlahlaAlpha-hemolysin precursor5.5  0.26 
    SA2003hlbhlbPhospholipase C3.2    
    SA2689icaAicaADBCIntercellular adhesion protein A75.656.8   
    SA2691icaB Intercellular adhesion protein B75.452.4   
    SA2462icaC Intercellular adhesion protein C (N315)1511.7   
    SA2690icaD Intercellular adhesion protein D109.277.3   
    SA1170katAkatACatalase (N315)4.33.1   
    SA0248lrgBlrgABlrgB protein  2.9  
    SA0860nucnucThermonuclease precursor19.38.24.9 2.4
    SA1812rotrotRepressor of toxins2.32.6   
    SA1758saksakStaphylokinase precursor (N315)  3  
    SA0901sspAsspABCSerine protease, V8  14.6  
    SA1056sspB1sspAB1CCysteine protease precursor  10.2  
    SA1055sspC SspC protein  7.7  
    SA1970sspB2sspB2, SA1971Cysteine protease precursor5.63.65.4  
    SA1971  Hypothetical protein4.83.46.7 2.6
    SA1819tst-1tst-1Toxic shock syndrome toxin 1 (N315)  5.70.14 
    SA1186 SA1186-SA1188Antibacterial protein (phenol-soluble modulin)3.9  0.010.01
    SA0480 SA0480Hypothetical protein40.736.8   
    SA1164 SA1164Fibrinogen binding-related protein4.76   
    SA2418 SA2418IgG binding protein SBI3.92.6   
    SA0270 SA0270Staphyloxanthin biosynthesis protein, putative5.6    
    SA0390 SA0390Lipase precursor (Mu50, MW2, MSSA476, MRSA252, N315 COL)7.33.3   
    SA0119sasDsasDCell wall surface anchor family protein4.43.3   
Boldface annotations indicate that a region of enrichment was found within the highlighted gene or within the intergenic region upstream of the highlighted gene.
Putative transcriptional unit.
Functional assignment based on the S. aureus COL strain annotation, unless otherwise indicated.
Expression ratio during exponential growth. The mutant strain is indicated in the table. The expression ratio of the mutant strain (codY, agr, or agr codY) relative to the wild type is shown.
Expression ratio during post-exponential growth. The mutant strain is indicated in the table. The expression ratio of the mutant strain (codY, agr, or agr codY) relative to the wild type is shown.
TABLE 3. Select genes that are underexpressed in the codY mutant of UAMS-1
Gene group and annotationaGeneGenetic organizationbAssignmentcExpression ratio    
    Expd Pxpe  
    codYagr codYcodYagragr codY
Sugar utilization and degradation        
    SA1042 SA1042-SA1043Hypothetical protein3.32.2   
    SA1043  Glycosyltransferase, group 1 family protein3.52.5   
Environmental stress response        
    SA2057rsbUrsbUVW, rpoFσB regulator protein  2.5 2.7
    SA2731 SA2731Cold shock protein, CSD family  3.1 3.3
    SA0096sarSsarSStaphylococcal accessory regulator S  3  
    SA0120 SA0120Transcriptional regulator, GntR family  2.2 3.5
    SA0245lytSlytSRSensor histidine kinase  2.7 4.1
    SA0307pfoRpfoRPerfringolysin O regulator protein  2.4  
    SA1060 SA1060Transcriptional regulator, MarR family  2.8 2.3
    SA2308 SA2308Phosphosugar binding transcriptional regulator, RpiR family
    SA2349 SA2349Transcriptional regulator, TetR family
Virulence factors        
    SA2294 SA2294Conserved hypothetical protein  2.4 2.6
    SA2295 SA2295Staphyloxanthin biosynthesis protein  3.3 4.4
    SA2584isaAisaAImmunodominant antigen A  3.2  
    SA0901 SA0901-SA0906Pathogenicity island protein3.73   
    SA0902  Pathogenicity island protein2.2    
    SA0903  Pathogenicity island protein2    
    SA1758saksakStaphylokinase precursor (N315)2.2    
    SAR2040 SAR2041-SAR2040Autolysin (MRSA252)4.1    
    SAV1954 SAV1955-SAV1950φ PVL ORF 18-19-like protein (Mu50)4.4    
    SA2511fnbAfnbAFibronectin binding protein A2.4    
    SA0023orfXorfXOrfX (N315)  2.8 2.5
Boldface indicates that a region of enrichment was found within the highlighted gene or within the intergenic region upstream of the highlighted gene.
Putative transcriptional unit.
Functional assignment based on the S. aureus COL strain, unless otherwise indicated.
Expression ratio during exponential growth. The mutant strain is indicated in the table. The expression ratio of the wild type relative to the mutant strain (codY, agr, or agr codY) is shown.
Expression ratio during post-exponential growth. The mutant strain is indicated in the table. The fold expression of the wild type relative to the mutant strain (codY, agr, or agr codY) is shown.
TABLE 4. Regions of the S. aureus genome selected by binding to CodY in vitro
Function of group and canonical box(es)a   De novo motif bEnrichment factorcGenome positiondPutative transcriptional uniteGene descriptionfExpression ratiog
Amino acid metabolism         
−40 3   48, −, TTTTCTGATTTTTTAGAAAGG271263288 thrA () IG (→)SA1361, hom , thrCB, SA1365Aspartate kinase, homoserine dehydrogenase54.2, 45.3
−6 3   4, +, TTTTCAGGTTATTCCAAAAAA311336491IG lysC , IGasd, dapABD, SA1433, dal, lysAAspartokinase21.9
3 2   4, +, TTGTTAAAATATTCTAAAAAT221338048IGlysC, IG asd , dapABD, SA1433, dal, lysAAspartate-semialdehyde dehydrogenase27
28 3   −29, −, ATATCAGAATTTTCTGATTAC2215763IG SA0012 Homoserine O-acetyltransferase6.8
52 2 −13 2 −53, −, TAGTTAGAATTGTCTAAAAAT892111452IG ilvDBHC, leuABCD, ilvADihydroxy-acid dehydratase202
    −3, +, ATTTCAGAATTTTCGAAACAC202115627IGilvDBHC , leuABCD, ilvAKetol-acid reductoisomerase236
     212119424IGilvDBHC, leuABCD, ilvA3-Isopropylmalate dehydratase118
38 1   −31, +, AATTTTGAATTTTTAGAAAAT20541652IG ilvE BCAA aminotransferase6.2
−61 2   60, −, AAATCAAAATTTTCTGAATAA49356777IG SA0431 , SA0430, SA0429, metE, SA0427trans-Sulfuration enzyme family protein86.2
14 2   −7, +, ATGTCTAAATTTTCTAATAAT26355320IG SA0431 , SA0430, SA0429, metE, SA0427trans-Sulfuration enzyme family protein 
−51 3   58, +, AACATAGAATATTCTGAAAAA72806009IG SA0870 LysE/YggA family protein7.5
−8 3   16, −, TAATCTGAAAATTCCTAATAT322650538IG SA2575 , SA2574Aspartate aminotransferase, class I10.5
−8 2   7, −, TACACCGAATTTTCTGAAAAA512789232IG hisZGD, SA2701, BHAFIConserved hypothetical protein17.3
−2 3 7 3 1, −, TTAACTGAAATTTCAAAAAAC26718943IG hisC Histidinol phosphate aminotransferase7.3
−10 0   9, −, TTTAGCAAATTTTCTGAAAAT251736733IG SA1772 , serAAminotransferase67.7
     241738502IGSA1772, serA d-3-Phosphoglycerate dehydrogenase72.1
−7 3   6, −, ATATCTGAATTTTCAGAAATG311740826SA1776- SA1774 Hydrolase haloacid dehalogenase-like family9.7
−3 3 6 3 2, −, TTAACCGAATATTCGAAATAT291310343IG trpEGDCFBAAnthranilate synthase component I2.9
    17, +, AAGTGTGAAGATTCAGAATAA281313511IGtrpEGD C FBAIndole-3-glycerol phosphate synthase34.6
−22 3   29, +, ATGTCAGAATTATCTTAATAT781441733IG aroCBA,SA1503-SA15003-Dehydroquinate synthase3.2
−113 3   157, +, GTTAAAAAATATTCTAACAAT211759183IG SA1787 Chorismate mutase/phospho-2-dehydro-3-deoxyheptonate aldolase5.8
    4, +, ATATCAGAATATTCTAAAAAA25433302IG gltABGlutamate synthase, large subunit41.7
0 2   8, +, TATTCTGAAAATTTCGAAATA341308768IG tyrA Prephenate dehydrogenase9.6
    5, +, TATTCTGAAATATGTGAATAA42982377purEKCS Q LFMNHDPhosphoribosylformylglycinamidine synthase I6.7
−6 3   5, −, AATTCTTAATTATCAGAATAT592691012IG SA2620 (SA2397 in N315)Similar to pyridoxal phosphate-dependent aminotransferase50.1
    240, +, TTATCGGATAGTTCTGGAAAT262395061IG SA2322 Peptidase9.9
14 3   −7, +, AATTCTGAAATTTCAGAAATT28182228IG SA0185 , SA0186, SA0187, ggtPeptide ABC transporter, permease protein28.7
−99 2   97, +, ATTTCAGAAAATTTTGAAGGG54894043IG oppBCDF, SA0995Oligopeptide ABC transporter, permease protein35.9
−28 2   −97, −, TTGTCTAAAAATTCTGAAAAA352687792IG SA2619 Amino acid permease61.6
7 3   0, +, TTTTCCTACTTTTCTAAACAT311991788IG SA1963 Proline permease4.8
    3, +, AAAATTGAAAATTCTCAAAAA2214546IG SA0010 , SA0011AzlC family protein7.2
0 3   8, +, TTAACTGAATATTTCGGAAAA45233878IG SA028-SA0232Transcriptional antiterminator, BglG family2.7
    72, +, TAATTTAAAAAATCTGAAAAA29298820IG brnQ2 , SACOL0203BCAA transport system II carrier protein8.9
−10 2   9, +, TTTTTCGAATTTTCCGAAATC30814085IG SA0882-SA0884ABC transporter, ATP binding protein6.8
−10 3   9, −, TATTTTAAATTTTCTAACAAA27812857   
1 2   −2, −, TTTGCCGAATTTTCTAAAAAA34424606IG SA0504-SA0506ABC transporter, ATP binding protein42.8
−1 1   0, −, TAATCTTAATTTTCAGAAAAG432385954IG SA2314-SA2312Sodium/bile acid symporter family protein12.7
    5, +, AAATCTTAAGATTCAGATTAT352598042IG SA2525, SA2626ABC transporter, ATP binding protein8
Carbon flow         
    10, +, TTATCTAATTAGTTAGAAAAT391028771IG pyc Pyruvate carboxylase5.9
    −6, +, GTTTGCGAATATTCTGATAAG351358559 sucA B2-Oxoglutarate dehydrogenase, E1 component4.6
    19, +, AATTTCGAATATTTAAATTTT3999390IG sodA Superoxide dismutase5.8
    25, +, ATCACCAAAATTTCTGATAGT212094935agrBD C A Accessory gene regulator A6.4
    5, −, AATTGCTAATTTTCTAATTTT26121388capABC D EFGHIJKLMNOPCapsular polysaccharide biosynthesis5.7
    40, +, TTTAAGGATTTATCTGAATGT28130063capABCDEFGHIJKL M NOPCapsular polysaccharide biosynthesis3.9§
−55 3   54, −, TACTCAAAATTTTCTTATAAT291078012IG hla Alpha-hemolysin precursor5.5
6 3   9, −, AAAACTTAAAATTTCGAATAA322029853IG hlb Phospholipase C3.2
−19 2   26, +, AAAAGCGAATTTTCTGAATAA442776864icaAD B CIntercellular adhesion protein B75.4
    −51, +, AAATTTGAAATTTTAGTTAAA321070247IG SA1164 Fibrinogen binding-related protein4.7
    8, +, TACGCTGAATGTTCTGAATTA272487229IG SA2418 IgG binding protein SBI3.9
    −6, +, TTTTTAGAATGTTCTGATAAA442713447IG gpxA2 Glutathione peroxidase6.7
2 3   5, +, AATTCTGAATTTTTAGATAAA352663219IG SA2585 Regulatory protein, putative133.2
−25 2   23, +, TTTACCGAAAATTGAAGAAAT2051514 SA0076 Hypothetical protein4.2
−22 3   20, +, ATATCTGAATATTTTGTTAAA3092377IG SA0111 Acetoin reductase12.8
26 3   −27, −, ATCAATGAATATTCTGACTAT21939605IG SA1033 Hypothetical protein14.3
−7 1   14, +, TACACTGACTTTTCCGAAAAT311724742IG SA1759 Universal stress protein family8.4
    14, −, TAAAATGAAAAATCAAAAAAT272678850IG SA2608 Hypothetical protein4.5
    −1, −, AAATTAGATTATTTAAAATTA48946756IG SA1042 Hypothetical protein0.3
The first number shown indicates the position of the first nucleotide in the canonical CodY box (≤3 mismatches) relative to the position of maximum enrichment and is followed by a boldface number that indicates the number of mismatches relative to the consensus sequence AATTTTCWGAAAATT. The negative or positive value associated with the number indicates whether the first nucleotide of the box was found upstream (−) or downstream (+) of the position of maximum enrichment. When multiple boxes were found, they appear in consecutive columns.
The number shown indicates the position of the first nucleotide in the de novo motif closest to the position of maximum enrichment. A negative or positive value for this first nucleotide in the motif indicates whether the motif was found upstream (−) or downstream (+) of the position of maximum enrichment, respectively. The plus (+) or minus (−) value following the position of the motif indicates on which strand the motif is found, relative to the genome. The sequence corresponding to the motif is shown.
The enrichment factor is for the position of maximum enrichment in the CodY pull-down sample (relative to the Acn pull-down sample) and corresponds to the identified motif(s) or the canonical box(es) indicated in the row.
The position in the NCTC 8325 genome of maximum enrichment in the CodY pull-down assay.
The putative transcriptional unit shown is based on the COL genome; the underlined regions correspond to the locations of the positions of maximum enrichment. The boldface text indicates the gene closest to the position of maximum enrichment whose overexpression ratio is displayed in the right-most column. IG, intergenic region.
The annotated function of the gene shown in boldface nearest the position of maximum enrichment is shown. When multiple gene names are shown in boldface, the function occurs in the order in which the genes occur within the transcriptional unit.
Overexpression during exponential growth in the codY mutant (relative to wild type) of the gene nearest to the position of maximum enrichment as identified in the CodY pull-down assay. When multiple expression ratios are shown, they refer to multiple genes and are listed in the order in which the underlined genes appear in the transcriptional unit. §, the overexpression value for the codY mutant during post-exponential growth (relative to wild type) of the gene nearest the position of maximum enrichment.


We thank Katie McCarty for construction of pKM1, Mark Smeltzer for providing strain UAMS929 and antibody to SarA, David Lazinski for helpful advice in designing the protocol for the affinity purification experiment, Kieran Pechter for providing purified B. subtilis aconitase, and Boris Belitsky for important suggestions and detailed criticism of the manuscript.
This work was supported by research grants (GM042219 to A.L.S. and AI037027 to C.Y.L.) from the U.S. National Institutes of Health and by funds from the University of Nebraska Medical Center awarded to P.M.D.

Supplemental Material

File (supplementary_material.pdf)
ASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse.


Bailey, T., and C. Elkan. 1994. Fitting a mixture model by expectation maximization to discover motifs in biopolymers. AAAI Press 2 : 28-36.
Beenken, K. E., P. M. Dunman, F. McAleese, D. Macapagal, E. Murphy, S. J. Projan, J. S. Blevins, and M. S. Smeltzer. 2004. Global gene expression in Staphylococcus aureus biofilms. J. Bacteriol. 186 : 4664-46684.
Belitsky, B. R., and A. L. Sonenshein. 2008. Genetic and biochemical analysis of CodY-binding sites in Bacillus subtilis. J. Bacteriol. 190 : 1224-1236.
Bennett, H., D. Pearce, S. Glenn, C. Taylor, M. Kuhn, A. Sonenshein, P. Andrew, and I. Roberts. 2007. Characterization of relA and codY mutants of Listeria monocytogenes: identification of the CodY regulon and its role in virulence. Mol. Microbiol. 63 : 1453-1467.
Blevins, J., K. Beenken, M. Elasri, B. Hurlburt, and M. Smeltzer. 2002. Strain-dependent differences in the regulatory roles of sarA and agr in Staphylococcus aureus. Infect. Immun. 70 : 470-480.
Bronner, S., H. Monteil, and G. Prevost. 2004. Regulation of virulence determinants in Staphylococcus aureus: complexity and applications. FEMS Microbiol. Rev. 28 : 183-200.
Cassat, J., P. Dunman, F. McAleese, E. Murphy, S. Projan, and M. Smeltzer. 2005. Comparative genomics of Staphylococcus aureus musculoskeletal isolates. J. Bacteriol. 187 : 576-592.
Cassat, J., P. Dunman, E. Murphy, S. Projan, K. Beenken, K. Palm, S. Yang, K. Rice, K. Bayles, and M. Smeltzer. 2006. Transcriptional profiling of a Staphylococcus aureus clincial isolate and its isogenic agr and sarA mutants reveals global differences in comparison to the laboratory strain RN6390. Microbiology 152 : 3075-3090.
Cheung, A., A. Bayer, G. Zhang, H. Gresham, and Y. Xiong. 2004. Regulation of virulence determinants in vitro and in vivo in Staphylococcus aureus. FEMS Immunol. Med. Microbiol. 40 : 1-9.
Cheung, A., M. Bayer, and J. Heinricks. 1997. sar genetic determinants necessary for transcription of RNAII and RNAIII in the agr locus of Staphylococcus aureus. J. Bacteriol. 179 : 3963-3971.
den Hengst, C. D., P. Curley, R. Larsen, G. Buist, A. Nauta, D. van Sinderen, O. P. Kuipers, and J. Kok. 2005. Probing direct interactions between CodY and the oppD promoter of Lactococcus lactis. J. Bacteriol. 187 : 512-521.
den Hengst, C. D., S. A. F. T. van Hijum, J. M. W. Geurts, A. Nauta, J. Kok, and O. P. Kuipers. 2005. The Lactococcus lactis CodY regulon, identification of a conserved cis-regulatory element. J. Biol. Chem. 280 : 34332-34342.
Dineen, S., A. Villapakkam, J. Nordman, and A. Sonenshein. 2007. Repression of Clostridium difficile toxin gene expression by CodY. Mol. Microbiol. 66 : 206-219.
Gillaspy, A., S. Hickmon, R. Skinner, J. Thomas, C. Nelson, and M. Smeltzer. 1995. Role of the accessory gene regulaory (agr) in pathogenesis of staphylococcal osteomyelitis. Infect. Immun. 63 : 3373-3380.
Guedon, E., B. Sperandio, N. Pons, S. Dusko Ehrlich, and P. Renault. 2005. Overall control of nitrogen metabolism in Lactococcus lactis by CodY, and possible models of CodY regulation in Firmicutes. Microbiology 151 : 3895-3909.
Guzman, L. M., D. Belin, M. J. Carson, and J. Beckwith. 1995. Tight regulation, modulation, and high-level expression by vectors containing the arabinose pBAD promoter. J. Bacteriol. 177 : 4121-4130.
Handke, L. D., R. P. Shivers, and A. L. Sonenshein. 2008. Interaction of Bacillus subtilis CodY with GTP. J. Bacteriol. 190 : 798-806.
Heinrichs, J., M. Bayer, and A. Cheung. 1996. Characterization of the sar locus and its interaction with agr in Staphylococcus aureus. J. Bacteriol. 178 : 418-423.
Hendriksen, W., H. Bootsma, S. Estevao, T. Hoogenboezem, A. de Jong, R. de Groot, O. Kuipers, and W. Hermans. 2008. CodY of Streptococcus pneumoniae: link between nutritional gene regulation and colonization. J. Bacteriol. 190 : 590-601.
Hsueh, Y., E. Somers, and A. Lee Wong. 2008. Characterization of the codY gene and its influence on biofilm formation in Bacillus cereus. Arch. Microbiol. 189 : 557-568.
Jefferson, K., D. Pier, D. Goldman, and G. Pier. 2004. The teichoplanin-associated locus regulator (TcaR) and the intercellular adhesin locus regulator (IcaR) are transcriptional inhibitors of the ica locus in Staphylococcus aureus. J. Bacteriol. 186 : 2449-2456.
Joseph, P., M. Ratnayake-Lecamwasam, and A. L. Sonenshein. 2005. A region of Bacillus subtilis CodY protein required for interaction with DNA. J. Bacteriol. 187 : 4127-4139.
Levdikov, V. M., E. Blagova, P. Joseph, A. L. Sonenshein, and A. J. Wilkinson. 2006. The structure of CodY, a GTP- and isoleucine-responsive regulator of stationary phase and virulence in Gram-positive bacteria. J. Biol. Chem. 281 : 11366-11373.
Li, H., J. Ruan, and R. Durbin. 2008. Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res. 18 : 1851-1858.
Lin, W. S., T. Cunneen, and C. Y. Lee. 1994. Sequence analysis and molecular characterization of genes required for the biosynthesis of type 1 capsular polysaccharide in Staphylococcus aureus. J. Bacteriol. 176 : 7005-7016.
Luong, T., S. Sau, M. Gomez, J. Lee, and C. Lee. 2002. Regulation of Staphylococcus aureus capsular polysaccharide expression by agr and sarA. Infect. Immun. 70 : 444-450.
Mahmood, R., and S. Khan. 1990. Role of upstream sequence in the expression of the staphylococcal enterotoxin B gene. J. Biol. Chem. 265 : 4652-4666.
Majerczyk, C. D., M. R. Sadykov, T. T. Luong, C. Lee, G. A. Somerville, and A. L. Sonenshein. 2008. Staphylococcus aureus CodY negatively regulates virulence gene expression. J. Bacteriol. 190 : 2257-2265.
Malke, H., and J. Ferretti. 2007. CodY-affected transcriptional gene expression of Streptococcus pyogenes during growth in human blood. J. Med. Microbiol. 56 : 707-714.
Malke, H., K. Steiner, W. McShan, and J. Ferretti. 2006. Linking the nutritional status of Streptococcus pyogenes to alteration of transcriptional gene expression: the action of CodY and RelA. Int. J. Med. Microbiol. 296 : 259-275.
Molle, V., Y. Nakaura, R. Shivers, H. Yamaguchi, R. Losik, Y. Fujita, and A. L. Sonenshein. 2003. Additional targets of the Bacillus subtilis global regulator CodY identified by chromatin immunoprecipitation and genome-wide transcript analysis. J. Bacteriol. 185 : 1911-1922.
Novick, R. 1991. Genetic systems in staphylococci. Methods Enzymol. 204 : 587-636.
Novick, R., and E. Geisinger. 2008. Quorum sensing in staphylococci. Annu. Rev. Genet. 42 : 541-564.
Novick, R. P. 2003. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol. Microbiol. 48 : 1429-1449.
Ouyang, S., S. Sau, and C. Lee. 1999. Promoter analysis of the cap8 operon, involved in type 8 capsular polysaccharide production in Staphylococcus aureus. J. Bacteriol. 181 : 2492-2500.
Peng, H., R. Novick, B. Kreiswirth, J. Kornblum, and P. Schlievert. 1988. Cloning, characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus aureus. J. Bacteriol. 170 : 4365-4372.
Petranovic, D., E. Guedon, B. Sperandio, C. Delorme, D. Ehrlich, and P. Renault. 2004. Intracellular effectors regulating the activity of the Lactococcus lactis CodY pleiotropic transcription regulator. Mol. Microbiol. 53 : 613-621.
Pohl, K., P. Francois, L. Stenz, F. Schlink, T. Geiger, S. Herbert, C. Goerke, J. Schrenzel, and C. Wolz. 2009. CodY in Staphylococcus aureus: a regulatory link between metabolism and virulence gene expression. J. Bacteriol. 191 : 2953-2963.
Ratnayake-Lecamwasam, M., P. Serror, K. Wong, and A. L. Sonenshein. 2001. Bacillus subtilis CodY represses early-stationary-phase genes by sensing GTP levels. Genes Dev. 15 : 1093-1103.
Richardson, A., S. Libby, and F. Fang. 2008. A nitric oxide-inducible lactate dehydrogenase enables Staphylococcus aureus to resist innate immunity. Science 319 : 1672-1676.
Sau, S., J. Sun, and C. Lee. 1997. Molecular characterization and transciprtional analysis of type 8 capsule genes in Staphylococcus aureus. J. Bacteriol. 179 : 1614-1621.
Serio, A., K. Pechter, and A. Sonenshein. 2006. Bacillus subtilis aconitase is required for efficient late-stage sporulation gene expression. J. Bacteriol. 188 : 6396-6405.
Shivers, R. P., and A. L. Sonenshein. 2004. Activation of the Bacillus subtilis global regulator CodY by direct interaction with branched-chain amino acids. Mol. Microbiol. 53 : 599-611.
Shivers, R. P., and A. L. Sonenshein. 2005. Bacillus subtilis ilvB operon: an intersection of global regulons. Mol. Microbiol. 56 : 1549-1559.
Somerville, G., M. Chaussee, C. Morgan, R. Fitzgerlad, D. Dorward, L. Reitzer, and J. Musser. 2002. Staphylococcus aureus aconitase inactivation unexpectedly inhibits post-exponential-phase growth and enhances stationary-phase survival. Infect. Immun. 70 : 6373-6382.
Somerville, G., and R. Proctor. 2009. At the crossroads of bacterial metabolism and virulence factor synthesis in staphylococci. Microbiol. Mol. Biol. Rev. 73 : 233-248.
Tu Quoc, P., P. Genevaux, M. Pajunen, H. Savilahti, C. Georgopoulos, J. Schrenzel, and W. Kelley. 2007. Isolation and characterization of biofilm formation-defective mutants of Staphylococcus aureus. Infect. Immun. 74 : 1079-1088.
Valle, J., A. Toledo-Arana, C. Berasain, J. Ghigo, B. Amorena, J. Penades, and I. Lasa. 2003. SarA and not sigma B is essential for biofilm development by Staphylococcus aureus. Mol. Microbiol. 48 : 1075-1087.
Vandenesch, F., J. Kornblum, and R. P. Novick. 1991. A temporal signal, independent of agr, is required for hla but not spa transcription in Staphylococcus aureus. J. Bacteriol. 173 : 6313-6320.
Villapakkam, A., L. D. Handke, B. R. Belitsky, V. M. Levdikov, A. J. Wilkinson, and A. L. Sonenshein. 2009. Genetic and biochemical analysis of the interaction of Bacillus subtilis CodY with branched-chain amino acids. J. Bacteriol. 191 : 6865-6875.

Information & Contributors


Published In

cover image Journal of Bacteriology
Journal of Bacteriology
Volume 192Number 111 June 2010
Pages: 2861 - 2877
PubMed: 20363936


Received: 1 March 2010
Accepted: 28 March 2010
Published online: 1 June 2010


Request permissions for this article.



Charlotte D. Majerczyk
Program in Molecular Microbiology, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts 02111
Paul M. Dunman
University of Nebraska Medical Center, Omaha, Nebraska 68198
Thanh T. Luong
University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205
Chia Y. Lee
University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205
Marat R. Sadykov
University of Nebraska, Lincoln, Nebraska 68583
Greg A. Somerville
University of Nebraska, Lincoln, Nebraska 68583
Kip Bodi
Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts 02111
Abraham L. Sonenshein [email protected]
Program in Molecular Microbiology, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts 02111
Department of Molecular Biology and Microbiology, Tufts University School of Medicine, Boston, Massachusetts 02111


Supplemental material for this article may be found at .

Metrics & Citations


Note: There is a 3- to 4-day delay in article usage, so article usage will not appear immediately after publication.

Citation counts come from the Crossref Cited by service.


If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

View Options

Figures and Media






Share the article link

Share with email

Email a colleague

Share on social media

American Society for Microbiology ("ASM") is committed to maintaining your confidence and trust with respect to the information we collect from you on websites owned and operated by ASM ("ASM Web Sites") and other sources. This Privacy Policy sets forth the information we collect about you, how we use this information and the choices you have about how we use such information.
FIND OUT MORE about the privacy policy